Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (151-160 of 1,123) with videos related to

Pageof 113
Sort By:
Cancers|August 12, 2022
IKKε Inhibitor Amlexanox Promotes Olaparib Sensitivity through the C/EBP-β-Mediated Transcription of Rad51 in Castrate-Resistant Prostate CancerSophie Gilbert, Benjamin Péant, Anne-Marie Mes-Masson, et al.
The Canadian Journal of Urology|January 9, 2003
Primary low-grade B-cell lymphoma of the urinary bladder: case report and literature reviewDaniel D Cohen, Claudine Lamarre, Louis Lamarre, et al.
Clinical Genitourinary Cancer|October 25, 2007
Continuing benefit of zoledronic acid in preventing skeletal complications in patients with bone metastasesFred Saad, Yin-Miao Chen, Donald M Gleason, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|September 20, 2018
Symptom assessment to guide treatment selection and determine progression in metastatic castration-resistant prostate cancer: Expert opinion and review of the evidenceFred Saad, Frédéric Pouliot, Brita Danielson, et al.
The Canadian Journal of Urology|January 13, 2006
An epidural abscess following transrectal ultrasound-guided biopsies of the prostateVincent Fradet, Michael McCormack, Paul Perrotte, et al.
Frontiers in Oncology|January 10, 2022
Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer PatientsAxel Cailleteau, Paul Sargos, Fred Saad, et al.
Cancers|August 26, 2022
Development of Olaparib-Resistance Prostate Cancer Cell Lines to Identify Mechanisms Associated with Acquired ResistanceMaxime Cahuzac, Benjamin Péant, Anne-Marie Mes-Masson, et al.
Nature Reviews. Urology|February 26, 2025
Assessing the effects of prostate cancer therapies on cardiovascular healthSteven Tisseverasinghe, Marwan Tolba, Boris Bahoric, et al.
Nature Reviews. Urology|June 5, 2025
Reply to 'Mitochondrial dysfunction as a crucial mediator of ADT-induced cardiovascular risk'Steven Tisseverasinghe, Marwan Tolba, Boris Bahoric, et al.
Asian Journal of Andrology|April 25, 2025
Sexual activity in men undergoing ADT for localized prostate cancer: a narrative literature reviewLaeticia Creidy, Daniel Taussky, Frederic Pouliot, et al.
Pageof 113

Showing results (151-160 of 1,123) with videos related to

Sort By:
Pageof 113
Cancers|August 12, 2022
IKKε Inhibitor Amlexanox Promotes Olaparib Sensitivity through the C/EBP-β-Mediated Transcription of Rad51 in Castrate-Resistant Prostate CancerSophie Gilbert, Benjamin Péant, Anne-Marie Mes-Masson, et al.
The Canadian Journal of Urology|January 9, 2003
Primary low-grade B-cell lymphoma of the urinary bladder: case report and literature reviewDaniel D Cohen, Claudine Lamarre, Louis Lamarre, et al.
Clinical Genitourinary Cancer|October 25, 2007
Continuing benefit of zoledronic acid in preventing skeletal complications in patients with bone metastasesFred Saad, Yin-Miao Chen, Donald M Gleason, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|September 20, 2018
Symptom assessment to guide treatment selection and determine progression in metastatic castration-resistant prostate cancer: Expert opinion and review of the evidenceFred Saad, Frédéric Pouliot, Brita Danielson, et al.
The Canadian Journal of Urology|January 13, 2006
An epidural abscess following transrectal ultrasound-guided biopsies of the prostateVincent Fradet, Michael McCormack, Paul Perrotte, et al.
Frontiers in Oncology|January 10, 2022
Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer PatientsAxel Cailleteau, Paul Sargos, Fred Saad, et al.
Cancers|August 26, 2022
Development of Olaparib-Resistance Prostate Cancer Cell Lines to Identify Mechanisms Associated with Acquired ResistanceMaxime Cahuzac, Benjamin Péant, Anne-Marie Mes-Masson, et al.
Nature Reviews. Urology|February 26, 2025
Assessing the effects of prostate cancer therapies on cardiovascular healthSteven Tisseverasinghe, Marwan Tolba, Boris Bahoric, et al.
Nature Reviews. Urology|June 5, 2025
Reply to 'Mitochondrial dysfunction as a crucial mediator of ADT-induced cardiovascular risk'Steven Tisseverasinghe, Marwan Tolba, Boris Bahoric, et al.
Asian Journal of Andrology|April 25, 2025
Sexual activity in men undergoing ADT for localized prostate cancer: a narrative literature reviewLaeticia Creidy, Daniel Taussky, Frederic Pouliot, et al.
Pageof 113